Granite Point Capital Management, L.P. - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 46 filers reported holding CHINA BIOLOGIC PRODS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Granite Point Capital Management, L.P. ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q1 2017$350,000
-6.9%
3,5000.0%0.10%
-65.0%
Q4 2016$376,000
-77.6%
3,500
-74.1%
0.30%
-54.3%
Q3 2016$1,680,000
-22.9%
13,500
-11.8%
0.66%
+101.2%
Q4 2015$2,180,000
+21.4%
15,300
-23.5%
0.33%
-73.5%
Q3 2015$1,796,000
-46.5%
20,000
-31.4%
1.23%
+26.0%
Q2 2015$3,358,000
-12.1%
29,160
-27.1%
0.98%
-30.2%
Q1 2015$3,820,000
+42.1%
40,0000.0%1.40%
+11.0%
Q4 2014$2,689,000
+42.4%
40,000
+14.3%
1.26%
+34.0%
Q3 2014$1,889,000
+21.4%
35,0000.0%0.94%
-12.2%
Q2 2014$1,556,00035,0001.07%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q2 2014
NameSharesValueWeighting ↓
WARBURG PINCUS LLC 10,989,200$1,049,578,0007.88%
RUDMAN ERROL M 110,201$10,525,0003.65%
Ativo Capital Management LLC 59,789$5,710,0002.24%
OBERWEIS ASSET MANAGEMENT INC/ 56,200$5,368,0001.51%
Granite Point Capital Management, L.P. 40,000$3,820,0001.40%
Cormorant Asset Management, LP 76,500$7,307,0001.13%
Spark Investment Management LLC 52,800$5,031,0000.70%
Grandeur Peak Global Advisors, LLC 33,050$3,157,0000.67%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 198,454$18,954,0000.66%
Visium Asset Management, LP 438,008$41,834,0000.62%
View complete list of CHINA BIOLOGIC PRODS INC shareholders